★ Private Action
Gilead Sciences donates $1M to Trump-Vance inaugural
Filed January 2025$1,000,000
★ The Brief
What happened
Gilead Sciences, Inc., an American biopharmaceutical company specializing in antiviral drugs for HIV/AIDS, hepatitis, influenza, and COVID-19 — and also developing medicines in oncology, inflammation, and cell therapy — contributed $1,000,000 to the Trump-Vance Inaugural Committee.
Who enabled it
Who benefits
Gilead Sciences donated $1,000,000 to the Trump-Vance Inaugural Committee in connection with the 2025 presidential inauguration. Gilead Sciences operates in the biotech products & research industry.
Actors
Who pushed it · 1Who initiated, paid, or pushed the action.
- Gilead Sciences
Donated $1,000,000 to the Trump-Vance Inaugural Committee.
Beneficiaries
Who gained · 1Who stood to gain.
- Trump-Vance Inaugural Committee
Received $1,000,000 from Gilead Sciences.
Further reading
- ★ Private ActionJanuary 2025Abbott Laboratories donates $500K to Trump-Vance inaugural
- ★ Private ActionJanuary 2025Adobe Inc donates $1M to Trump-Vance inaugural
- ★ Private ActionJanuary 2025Af Holdco LLC donates $500K to Trump-Vance inaugural
- ★ Private ActionJanuary 2025Alexander Shustorovish donates $1M to Trump-Vance inaugural
- ★ Private ActionJanuary 2025Alpha Metallurgical Resources donates $500K to Trump-Vance inaugural
- ★ Private ActionJanuary 2025Altria Group donates $1M to Trump-Vance inaugural